Lv11
90 积分 2023-04-06 加入
Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines
1年前
已完结
Abstract CT190: A multicenter, open-label, single-arm, phase II study: The third generation EGFR tyrosine kinase inhibitor almonertinib for pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (APOLLO)
1年前
已关闭
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
1年前
已完结
皖公网安备34019202002308
